01 4Gowling WLG (Canada) LLP
01 42432178
01 4Guanfacine Hydrochloride
01 4Extended Release Tablet
01 42021-12-20
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-20
Brand Name : INTUNIV XR
Patent Number : 2432178
Filing Date : 2001-12-20
Strength per Unit : 1 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-20
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-20
Brand Name : INTUNIV XR
Patent Number : 2432178
Filing Date : 2001-12-20
Strength per Unit : 2 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-20
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-02
Brand Name : INTUNIV XR
Patent Number : 2432178
Filing Date : 2001-12-20
Strength per Unit : 3 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-02
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-20
Brand Name : INTUNIV XR
Patent Number : 2432178
Filing Date : 2001-12-20
Strength per Unit : 4 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-12-20
Date Granted : 2010-04-20
LOOKING FOR A SUPPLIER?
